JMIR Bioinformatics and Biotechnology at MCBIOS 2026

As the landscape of computational biology continues to evolve, fostering strong ties between specialized societies and high-impact scholarly publishing is essential. We are pleased to announce that both the Editor-in-Chief and I, the Managing Editor of JMIR Bioinformatics and Biotechnology, will be presenting a brief talk at the upcoming MCBIOS 2026 conference (March 27–29, 2026, Moffitt Cancer Center, Tampa, FL). Our talk will focus on a new collaboration and an open call for submissions designed to highlight innovative research in the fields of computational biology, artificial intelligence, and health care innovation.

A Strategic Alliance: What It Is

The core of our upcoming talk at MCBIOS 2026 is to introduce and highlight our partnership with the MidSouth Computational Biology and Bioinformatics Society. Through this collaboration, JMIR Bioinformatics and Biotechnology serves as an official journal partner, providing a high-impact, open access platform for society members to publish their work. This initiative supports the dissemination of research presented at MCBIOS while enhancing the visibility and global reach of the society’s scholarship. By aligning our editorial priorities with the society’s mission, we aim to strengthen the impact of MCBIOS research and offer members a clear pathway to peer-reviewed publication.

Advancing the Field: Call for Papers

In conjunction with this partnership, we are promoting a Call for Papers and invite submissions of original research, reviews, and methodological work aligned with the 2026 conference themes. We particularly welcome contributions advancing the integration of computational biology, artificial intelligence, and health innovation, including AI-driven medical applications, computational genomics and multi-omics analysis, AI-enabled drug discovery, and emerging technologies such as large language models, radiogenomics, and digital twin frameworks for personalized and predictive health care.

This call aims to bring together interdisciplinary research at the intersection of data science, biology, and clinical innovation, supporting the advancement of next-generation bioinformatics and translational health research.

Value for the Community: How Do MCBIOS Members Benefit?

This partnership is designed to provide meaningful advantages to the MCBIOS research community by offering a dedicated, high-quality open access publishing pathway through JMIR Bioinformatics and Biotechnology. It supports the dissemination of research through dedicated theme issues and the expansion of conference abstracts into full papers, while ensuring broad visibility within an open science framework. MCBIOS members also benefit from financial and professional support, including discounted article processing fees, opportunities for editorial involvement, and access to publishing education resources. In addition, the partnership emphasizes timely peer review and rapid publication, enabling high-quality computational biology and bioinformatics research to reach the global scientific community when it is most relevant.

About JMIR Bioinformatics and Biotechnology

JMIR Bioinformatics and Biotechnology is a premier, peer-reviewed, open-access journal indexed in PubMed, PubMed Central, and Scopus. By emphasizing both basic science and translational research, the journal provides a robust platform for bioinformaticians, biologists, computer scientists, and clinicians to collaborate on the integration of large-scale genomic data with clinical and pathological information.

Join the Conversation

We look forward to connecting with colleagues and contributors during our session at MCBIOS 2026. We also encourage you to review our partnership announcement and submission guidelines to learn how your work can contribute to the future of bioinformatics.